Dr. Lu Hongzhou
卢洪洲
President; Chief Physician; Professor (Grade II); Doctoral Supervisor
Where they practice, who they consult.
- Shenzhen Third People's Hospital (National Clinical Research Center for Infectious Diseases), Shenzhen
- 30+ years in infectious disease medicine
- English, Mandarin
What they personally lead.
Training and recognition
First clinician globally to identify and report a human H7N9 avian influenza case; led clinical rescue efforts during SARS, H1N1, and COVID-19 outbreaks; headed China's National Key R&D Programs on AIDS-tuberculosis co-infection across the 11th, 12th, and 13th Five-Year Plans; elected Fellow of the American Academy of Microbiology (2022); co-recipient of the French Gruber-Chaponack-Dubouchet Prize (2020) for COVID-19 origin research; completed postdoctoral training at the University of Pittsburgh
What to expect
Dr. Lu leads Shenzhen's primary infectious disease hospital, which serves as a national clinical research center. International patients with HIV/AIDS, drug-resistant infections, or emerging infectious diseases can access care through the hospital's international services. Shenzhen is highly accessible from Hong Kong.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Lu Hongzhou's background to other specialists in Shenzhen. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.